Susquehanna International Group Portfolio holdings
Susquehanna International Group (SIG), founded in 1987 by Jeff Yass and a group of friends, is a privately held global quantitative trading and technology firm headquartered in Bala Cynwyd, Pennsylvania. Specializing in trading equities, fixed income, commodities, derivatives, and ETFs, SIG has grown into a major market maker, handling around 600 equity options and 45 index options across exchanges like the CBOE, while employing over 3,000 people worldwide. The firm leverages a data-driven, probabilistic approach—rooted in the founders’ poker-playing days—to provide liquidity and competitive pricing in financial markets, with additional ventures in private equity, venture capital (notably an early investment in ByteDance, TikTok’s parent company), and sports betting analytics. Known for its innovative culture and use of game theory, SIG operates offices across North America, Europe, Asia, and Australia, maintaining a low-profile yet influential presence in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.85% |
| 2 | Consumer Discretionary | 1.02% |
| 3 | Financials | 0.76% |
| 4 | Communication Services | 0.62% |
| 5 | Healthcare | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11476
CALL
Aclaris Therapeutics
ACRS
$873M
| $31.2K | ﹤0.01% |
27,100
+7,900
| +41% | +$9.69K |
|
11477
CALL
Taysha Gene Therapies
TSHA
$1.99B
| $31.2K | ﹤0.01% |
15,500
-34,000
| -69% | -$74.6K |
|
|
ADAP
11478
CALL
DELISTED
Adaptimmune Therapeutics
ADAP
| $31.1K | ﹤0.01% |
32,700
+21,000
| +179% | +$23.8K |
|
|
TAIT
11479
DELISTED
Taitron Components
TAIT
| $31K | ﹤0.01% |
+10,667
| New | +$30.5K |
|
11480
PUT
Talkspace
TALK
$871M
| $30.7K | ﹤0.01% |
+14,700
| New | +$28.7K |
|
11481
CALL
AbCellera Biologics
ABCL
$3.35B
| $30.7K | ﹤0.01% |
11,800
-51,700
| -81% | -$143K |
|
|
SOL
11482
PUT
DELISTED
Emeren Group
SOL
| $30.5K | ﹤0.01% |
+11,300
| New | +$21K |
|
|
IVA
11483
Inventiva
IVA
$1.1B
| $30.2K | ﹤0.01% |
+16,327
| New | +$38.2K |
|
11484
System1
SST
$18.9M
| $29.9K | ﹤0.01% |
2,667
-5,680
| -68% | -$72.9K |
|
11485
CALL
Ring Energy
REI
$349M
| $29.8K | ﹤0.01% |
18,600
-22,500
| -55% | -$40.2K |
|
|
BCLI
11486
CALL
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $29.3K | ﹤0.01% |
8,493
-120
| -1% | -$566 |
|
11487
BuzzFeed
BZFD
$92.5M
| $29.2K | ﹤0.01% |
10,968
-23,235
| -68% | -$61.9K |
|
11488
Codere Online Luxembourg Warrants
CDROW
$5.02M
| $29.1K | ﹤0.01% |
+29,401
| New | +$29.6K |
|
11489
Research Solutions
RSSS
$75.3M
| $28.8K | ﹤0.01% |
+10,562
| New | +$28.4K |
|
|
UBX
11490
CALL
DELISTED
Unity Biotechnology
UBX
| $28.8K | ﹤0.01% |
19,600
-8,300
| -30% | -$12.2K |
|
11491
Fortress Biotech
FBIO
$92.7M
| $28.7K | ﹤0.01% |
19,862
+1,011
| +5% | +$1.93K |
|
|
RVPH
11492
PUT
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $28.7K | ﹤0.01% |
995
-785
| -44% | -$17.4K |
|
11493
PUT
ProQR Therapeutics
PRQR
$267M
| $28.4K | ﹤0.01% |
+15,600
| New | +$29.3K |
|
11494
Fuel Tech
FTEK
$46.8M
| $28.4K | ﹤0.01% |
+27,011
| New | +$27.7K |
|
11495
Nexalin Technology
NXL
$7.84M
| $28.4K | ﹤0.01% |
+42,383
| New | +$43.7K |
|
|
NB
11496
PUT
NioCorp Developments
NB
$747M
| $28.3K | ﹤0.01% |
13,000
+2,600
| +25% | +$4.77K |
|
11497
Alzamend Neuro
ALZN
$6.95M
| $28.1K | ﹤0.01% |
+1,845
| New | +$48.3K |
|
11498
PUT
Dragonfly Energy
DFLI
$18.2M
| $28K | ﹤0.01% |
588
+191
| +48% | +$11.4K |
|
|
ICAD
11499
DELISTED
iCAD Inc
ICAD
| $28K | ﹤0.01% |
17,901
-53,199
| -75% | -$76.3K |
|
|
SLI
11500
PUT
Standard Lithium
SLI
$586M
| $28K | ﹤0.01% |
17,400
-5,500
| -24% | -$7.08K |
|
Similar funds
Susquehanna International Group's Q3 2024 Portfolio in Review
As of Q3 2024, Susquehanna International Group held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Susquehanna International Group's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, down from 2.4% a quarter earlier, followed by Consumer Discretionary and Financials.
- Susquehanna International Group's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Susquehanna International Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Susquehanna International Group's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Susquehanna International Group fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Susquehanna International Group's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Susquehanna International Group opened 1,572 new positions and closed 1,625 in Q3 2024.
- Susquehanna International Group's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.